Enkephalinase inhibitors: potential agents for the management of pain
about
Entropy-driven binding of opioid peptides induces a large domain motion in human dipeptidyl peptidase IIIProposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor.Active site mutations change the cleavage specificity of neprilysin.Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management.Dipeptidyl peptidase III: a multifaceted oligopeptide N-end cutter.Roles of proteolysis in regulation of GPCR function.Antitumor activity of opiorphin, sialorphin and their conjugates with a peptide klaklakklaklak.Anti-inflammatory effect of novel analogs of natural enkephalinase inhibitors in a mouse model of experimental colitis.The Development of Translational Biomarkers as a Tool for Improving the Understanding, Diagnosis and Treatment of Chronic Neuropathic Pain.Zinc inhibits apoptosis and maintains NEP downregulation, induced by ropivacaine, in HaCaT cells.Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum.Spinorphin inhibits membrane depolarization- and capsaicin-induced intracellular calcium signals in rat primary nociceptive dorsal root ganglion neurons in culture.Contribution of Delta-Opioid Receptors to Pathophysiological Events Explored by Endogenous Enkephalins.Potentiation of [Met5]enkephalin-induced antinociception by mixture of three peptidase inhibitors in rat.The Coordination Abilities of Three Novel Analogues of Saliva Peptides: The Influence of Structural Modification on the Copper Binding.Orphan neuropeptides and receptors: Novel therapeutic targets.Attenuating the Agent: Reducing Opioid “Virulence”
P2860
Q27678433-AA604B67-E726-4B6E-9C27-2205928E578FQ33630464-141E59B7-BDBF-4657-8025-38675C9C680FQ34182580-7A897A59-7B5E-4ADF-A032-93C90445B14AQ35598669-589EBE94-09AC-4729-9C2A-9997A49A3C10Q37474355-CE43650E-FFF2-4590-9C4C-2CCBB8EDB727Q37906790-D692EFAE-BE56-4F7B-9B6F-8D1DFA3B224AQ38050189-91E85B4E-1366-4968-90B7-A4DAEF7EEAC5Q38730361-D715501D-AA2A-4EB2-B8BF-F78DF3692FCDQ38795301-806AAE2E-1B04-42CD-B570-67FDF72A38D8Q38865560-F8AD2EFB-E72E-45AE-A7C1-D84998297A7AQ39277551-9E5B395B-7EB6-45AA-880C-A2FCDC903EFFQ39472701-90149F01-30CB-4DA1-AD53-65104AB900ADQ40859212-FFFDC137-0C30-45AB-BC0A-149728C6BEA7Q44338644-47FF41E8-5363-4E2B-818A-4BFA604EE15CQ44430373-94943FFC-19DC-4305-B56B-B3D7275FBE7FQ47119064-B365E8AE-B6C0-42BB-9BBD-08D53C3B5B19Q47366066-ACD72EA6-5E4D-4269-B006-884D46C3E2E0Q57462886-FA88D514-C6EA-431D-8969-54ADF62ECCF5
P2860
Enkephalinase inhibitors: potential agents for the management of pain
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Enkephalinase inhibitors: potential agents for the management of pain
@ast
Enkephalinase inhibitors: potential agents for the management of pain
@en
Enkephalinase inhibitors: potential agents for the management of pain
@nl
type
label
Enkephalinase inhibitors: potential agents for the management of pain
@ast
Enkephalinase inhibitors: potential agents for the management of pain
@en
Enkephalinase inhibitors: potential agents for the management of pain
@nl
prefLabel
Enkephalinase inhibitors: potential agents for the management of pain
@ast
Enkephalinase inhibitors: potential agents for the management of pain
@en
Enkephalinase inhibitors: potential agents for the management of pain
@nl
P2093
P1433
P1476
Enkephalinase inhibitors: potential agents for the management of pain
@en
P2093
P304
P356
10.2174/138945008785909356
P407
P577
2008-10-01T00:00:00Z